Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression
DOI10.3934/MBE.2021094zbMATH Open1471.92098OpenAlexW3129461178MaRDI QIDQ1981122FDOQ1981122
Authors: Marios G. Krokidis, Themis P. Exarchos, Panagiotis Vlamos 
Publication date: 9 September 2021
Published in: Mathematical Biosciences and Engineering (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.3934/mbe.2021094
Recommendations
- Statistical methods for proteomic biomarker discovery based on feature extraction or functional modeling approaches
- Artificial intelligence applied to neuroimaging data in Parkinsonian syndromes: actuality and expectations
- Biomarker assessment and combination with differential covariate effects and an unknown gold standard, with an application to Alzheimer's disease
- Mapping the Genetic-Imaging-Clinical Pathway with Applications to Alzheimer’s Disease
- Leveraging nonlinear dynamic models to predict progression of neuroimaging biomarkers
data analysisomicsAlzheimer's diseasebiomarkersParkinson's diseaseneurogenerative diseasesneuronal loss
Neural biology (92C20) Research exposition (monographs, survey articles) pertaining to biology (92-02) Pathology, pathophysiology (92C32)
This page was built for publication: Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1981122)
